March. 25, 2020
Determining the optimal dose of tenecteplase before endovascular thrombectomyThe first randomized controlled trial to compare tenecteplase dosing found no difference in adverse events, cerebral reperfusion or in functional outcomes for 0.40 mg/kg prior to endovascular thrombectomy compared to a 0.25 mg/kg dose. READ MORE
Endovascular therapy with versus without intravenous tissue plasminogen activator compared in acute stroke with ICA and M1 occlusionThe debate over direct endovascular venous treatment, thrombectomy, for stroke versus bridging therapy with intravenous treatment, thrombolysis, before EVT is one step closer to resolution. READ MORE
Mark your calendar for ISC21The International Stroke Conference 2021 is scheduled for Feb. 10-12, 2021, in Denver, Colorado. The Pre-Conference Symposia and the State-of-the-Science Stroke Nursing Symposium will be held Feb. 9, the day prior to the beginning of ISC21. READ MORE